Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print RSS Feed

Breaking News

Related Searches:
Pfizer To Acquire Brazilian Generics Stake

October 20, 2010
Pfizer will acquire a 40% stake in Teuto, expanding its presence in Brazil.  Read More »
Financial Report: Abbott 3Q

October 20, 2010
Growth in the quarter was driven by worldwide pharmaceutical sales, up 22% to $4.9 billion.   Read More »
Financial Report: Gilead 3Q

October 20, 2010
Product sales were up 13% to $1.9 billion in the quarter. Antiviral product sales were $1.7 billion (+12%).  Read More »
Particle Sciences To Offer SoluBest Technology

October 20, 2010
Particle Sciences Inc. (PSI) and SoluBest have entered into a licensing and technology development agreement under which PSI will be the exclusive contract research provider in the U.S. for SoluBest's Solumer technology.  Read More »
Financial Report: Johnson & Johnson 3Q

October 19, 2010
Worldwide Pharmaceutical sales were $5.5 billion in the quarter (+5%), with operational growth of 6% and a negative impact from currency of 1%.  Read More »
Althea Expands Prefilled Capacity

October 19, 2010
Althea Technologies, Inc. has completed the installation of a new INOVA H3-5 high-speed syringe filling line at its large scale and commercial manufacturing facility in San Diego, CA.  Read More »
Galapagos Achieves Milestones in Two Alliances

October 19, 2010
Galapagos has achieved two milestones totaling $3.5 million in its strategic alliances with Janssen Pharmaceutica and GlaxoSmithKline.   Read More »
Biocon, Pfizer Enter Biosimilar Commercialization Pact

October 18, 2010
Biocon and Pfizer have entered into a strategic agreement for the worldwide commercialization of Biocon's biosimilar versions of Insulin and Insulin analog products.  Read More »
Almac’s UK Site Completes Successful Inspection

October 18, 2010
The Medicines and Healthcare products Regulatory Agency (MHRA) has successfully completed an inspection of Almac’s Clinical Services UK facility in Craigavon.  Read More »
Goodwin Biotech Signs Mfg. Pact

October 18, 2010
Goodwin Biotechnology, Inc. has signed a development and manufacturing agreement with a multinational biopharmaceutical client, under which Goodwin will develop the process to manufacture a therapeutic monoclonal antibody conjugate for diagnostic imaging   Read More »
Generic Hyzaar and Cozaar Approved by FDA

October 15, 2010
Mylan Pharmaceuticals, Inc. received approval from the FDA for its ANDAs for the generic versions of antihypertensive drugs Hyzaar Tablets, 50 mg/12.5 mg and 100 mg/25 mg, and Cozaar Tablets, 25 mg, 50 mg and 100 mg.  Read More »
Aldagen, Inc.

October 15, 2010
Lyle A. Hohnke, Ph.D. has been appointed chief executive officer of Aldagen, Inc.   Read More »
Discovery Labs

October 15, 2010
W. Thomas Amick has been appointed chief executive officer of Discovery Laboratories, Inc.   Read More »
Financial Report: Roche 3Q

October 14, 2010
Pharmaceutical sales were up 2% attributed to Avastin, MabThera/Rituxan, Herceptin, Lucentis, Actemra/RoActemra and Xeloda.  Read More »
Catalent’s Eberbach Site Marks 60th Year

October 14, 2010
Catalent’s R.P. Scherer softgel business based in Eberbach, Germany celebrated 60 years of service to the health care industry providing a broad range of encapsulation products and services including formulation development of new products, developm  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: